As bones age, they may weaken or grow abnormally. Osteoporosis and Paget's disease, though different, both affect bone health ...

Worryingly, the brittle-bone disease is no longer an illness that ... This means that the more protein you eat, the more calcium you need. As people don't usually eat enough, it tends to be ...

Black was born with osteogenesis imperfecta (OI), a genetic or heritable disease ... bones break extremely easily, often with no obvious cause. While no one knows the exact number of people ...

Saskatchewan got hit with its first major snowstorm of the season Monday night. By Tuesday morning, many physically disabled ...

Baylor College of Medicine is conducting this OI Wellbeing Study as a part of the Brittle Bone Disease Consortium which aims to improve the lives of people with Osteogenesis Imperfecta. This study ...

HKDSE high scorer Cherry Ho didn't let brittle bone disease or numerous hospital visits ... and see themselves as no different from other people.

Here, she talks about living with brittle bone disease. Many people assume that I'm an able-bodied actress playing a disabled character. When people do recognise me, they often show surprise that ...

Madam Kumari, as she is known, has osteoporosis or brittle bones. The condition typically ... But mostly, says Dr Chew, osteoporosis is a silent disease. “People may realise they have the ...

Actor Brian Cox presents an appeal on behalf of the Brittle Bone Society, a charity focused on improving access to care, research and campaigning for those who live with the disease.

Jasmine, from Nottingham, was diagnosed with osteogenesis imperfecta, known as brittle bone disease, after breaking eight bones by the age of 11. Successful reconstruction work was carried out on ...

Osteoporosis is a bone disease characterized by decreased bone density and strength, leading to fragile, brittle bones that ... Although it’s typical for most people to lose height as they ...

Mereo’s drug candidate for brittle bone disease missed its primary endpoint in a recent phase 2b study, but analysts at Cantor Fitzgerald reckon that may not stop the drug getting approved.